HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Yang Selected Research

gentiopicroside

1/2022Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway.
1/2020Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Yang Research Topics

Disease

253Neoplasms (Cancer)
12/2022 - 02/2002
88Inflammation (Inflammations)
08/2022 - 02/2002
50Fibrosis (Cirrhosis)
08/2022 - 07/2008
42Insulin Resistance
11/2022 - 03/2002
42Infections
03/2022 - 02/2006
40Pain (Aches)
01/2022 - 03/2013
39Hepatocellular Carcinoma (Hepatoma)
02/2022 - 09/2003
39Neoplasm Metastasis (Metastasis)
01/2022 - 08/2005
34Hypertension (High Blood Pressure)
05/2022 - 01/2003
34Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2002
32Stomach Neoplasms (Stomach Cancer)
01/2022 - 07/2008
29Carcinogenesis
05/2022 - 06/2002
27Hypoxia (Hypoxemia)
05/2022 - 03/2011
26Obesity
11/2022 - 09/2004
26Atherosclerosis
07/2022 - 02/2002
26Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 12/2009
26Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2012
22Lung Neoplasms (Lung Cancer)
01/2022 - 06/2002
21Breast Neoplasms (Breast Cancer)
12/2022 - 08/2008
19Neuralgia (Stump Neuralgia)
10/2020 - 07/2013
17Liver Cirrhosis (Hepatic Cirrhosis)
05/2022 - 12/2008
17Non-alcoholic Fatty Liver Disease
11/2021 - 04/2012
17Body Weight (Weight, Body)
09/2021 - 02/2006
16Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 10/2004
14Carcinoma (Carcinomatosis)
10/2022 - 12/2002
14Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2006
13Ischemia
01/2021 - 06/2010
13Hyperalgesia
10/2020 - 01/2014
13Thrombosis (Thrombus)
01/2020 - 01/2004
12Ischemic Stroke
07/2022 - 04/2014
12COVID-19
03/2022 - 01/2020
12Hypersensitivity (Allergy)
10/2021 - 03/2013
12Myocardial Infarction
01/2021 - 11/2013
11Asthma (Bronchial Asthma)
03/2022 - 11/2011
11Sepsis (Septicemia)
01/2021 - 01/2013
11Stroke (Strokes)
10/2020 - 11/2013
10Parkinson Disease (Parkinson's Disease)
10/2022 - 01/2014
10Autoimmune Diseases (Autoimmune Disease)
01/2022 - 06/2007
10Adenocarcinoma of Lung
01/2022 - 06/2002
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2015
10Virus Diseases (Viral Diseases)
04/2021 - 10/2008
10Reperfusion Injury
03/2021 - 04/2013
9Disease Progression
10/2022 - 12/2009
9Wounds and Injuries (Trauma)
01/2022 - 04/2014
9Diabetes Mellitus
12/2020 - 11/2012
8Atrial Fibrillation
02/2022 - 01/2006
8Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2022 - 06/2010
8Adenocarcinoma
01/2022 - 08/2008
8Leukemia
12/2021 - 04/2005
8Pneumonia (Pneumonitis)
11/2021 - 09/2010
8Osteoporosis
09/2021 - 04/2011

Drug/Important Bio-Agent (IBA)

109Proteins (Proteins, Gene)FDA Link
05/2022 - 02/2002
63Pharmaceutical PreparationsIBA
08/2022 - 05/2004
54Biomarkers (Surrogate Marker)IBA
12/2022 - 12/2011
41Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2002
34CytokinesIBA
04/2022 - 06/2002
33Messenger RNA (mRNA)IBA
05/2022 - 01/2006
32Biological ProductsIBA
05/2022 - 09/2012
31MicroRNAs (MicroRNA)IBA
01/2022 - 11/2011
27LipidsIBA
04/2022 - 05/2002
26Insulin (Novolin)FDA Link
11/2022 - 03/2002
22Therapeutic UsesIBA
05/2022 - 09/2003
18Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2022 - 12/2002
18Long Noncoding RNAIBA
05/2022 - 01/2018
18Small Interfering RNA (siRNA)IBA
01/2022 - 08/2008
17Anthocyanins (Anthocyanin)IBA
07/2022 - 04/2011
17AntioxidantsIBA
01/2022 - 01/2011
17Antiviral Agents (Antivirals)IBA
01/2022 - 02/2006
17DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2005
16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 06/2002
16Cisplatin (Platino)FDA LinkGeneric
01/2022 - 04/2012
15EnzymesIBA
10/2021 - 02/2006
15RNA (Ribonucleic Acid)IBA
06/2021 - 05/2005
14Interleukin-6 (Interleukin 6)IBA
03/2022 - 06/2002
13Blood Glucose (Blood Sugar)IBA
08/2022 - 09/2004
13CollagenIBA
05/2022 - 12/2008
12Peptides (Polypeptides)IBA
08/2022 - 09/2003
12InflammasomesIBA
07/2022 - 04/2012
12Transforming Growth Factors (Transforming Growth Factor)IBA
03/2022 - 02/2010
12Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 01/2012
12Triglycerides (Triacylglycerol)IBA
11/2020 - 05/2002
9Sirtuin 1IBA
01/2022 - 01/2017
9AntigensIBA
10/2021 - 09/2003
9Immunoglobulin G (IgG)IBA
10/2021 - 05/2014
9Indicators and Reagents (Reagents)IBA
01/2021 - 02/2010
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 07/2008
9Phosphotransferases (Kinase)IBA
01/2021 - 03/2005
8AntibodiesIBA
11/2022 - 08/2007
8CholesterolIBA
01/2022 - 05/2002
8HydrogelsIBA
11/2021 - 12/2015
8LigandsIBA
10/2021 - 06/2011
8Tyrosine Kinase InhibitorsIBA
06/2021 - 06/2014

Therapy/Procedure

112Therapeutics
10/2022 - 05/2004
37Drug Therapy (Chemotherapy)
01/2022 - 09/2003
19Radiotherapy
01/2022 - 05/2011
17Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2021 - 05/2004
14Aftercare (After-Treatment)
10/2021 - 10/2006
13Immunotherapy
05/2022 - 11/2012
9Transplantation
04/2022 - 08/2009
9Injections
09/2021 - 07/2008